| __timestamp | Bio-Techne Corporation | Gilead Sciences, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 106352000 | 3788000000 |
| Thursday, January 1, 2015 | 144969000 | 4006000000 |
| Friday, January 1, 2016 | 162364000 | 4261000000 |
| Sunday, January 1, 2017 | 188462000 | 4371000000 |
| Monday, January 1, 2018 | 210850000 | 4853000000 |
| Tuesday, January 1, 2019 | 240515000 | 4675000000 |
| Wednesday, January 1, 2020 | 255497000 | 4572000000 |
| Friday, January 1, 2021 | 298182000 | 6601000000 |
| Saturday, January 1, 2022 | 349103000 | 5657000000 |
| Sunday, January 1, 2023 | 366887000 | 6498000000 |
| Monday, January 1, 2024 | 389335000 | 28675800000 |
Unleashing the power of data
In the ever-evolving landscape of biotechnology, understanding cost structures is pivotal. This analysis delves into the cost of revenue trends for Gilead Sciences, Inc. and Bio-Techne Corporation from 2014 to 2023. Over this decade, Gilead Sciences consistently reported higher costs, peaking in 2021 with a 74% increase from 2014. Meanwhile, Bio-Techne's cost of revenue grew steadily, marking a 266% rise by 2023. This stark contrast highlights Gilead's expansive operations compared to Bio-Techne's more measured growth. Notably, 2023 data for Gilead is missing, suggesting potential shifts in their financial strategy. As the biotech sector continues to innovate, these insights offer a glimpse into the financial underpinnings that drive industry leaders.
Comparing Cost of Revenue Efficiency: Amgen Inc. vs Gilead Sciences, Inc.
Amgen Inc. vs Bio-Techne Corporation: Efficiency in Cost of Revenue Explored
Gilead Sciences, Inc. vs Insmed Incorporated: Efficiency in Cost of Revenue Explored
Gilead Sciences, Inc. and Bio-Techne Corporation: A Comprehensive Revenue Analysis
Cost of Revenue Trends: Gilead Sciences, Inc. vs Veracyte, Inc.
Cost Insights: Breaking Down Gilead Sciences, Inc. and Wave Life Sciences Ltd.'s Expenses
Cost of Revenue: Key Insights for Gilead Sciences, Inc. and Iovance Biotherapeutics, Inc.
Cost of Revenue Trends: Gilead Sciences, Inc. vs Geron Corporation
Comparing Cost of Revenue Efficiency: Gilead Sciences, Inc. vs Travere Therapeutics, Inc.
Cost of Revenue Trends: Gilead Sciences, Inc. vs MiMedx Group, Inc.
United Therapeutics Corporation vs Bio-Techne Corporation: Efficiency in Cost of Revenue Explored
Bio-Techne Corporation vs Amneal Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored